Greenwich LifeSciences Ownership | Who Owns Greenwich LifeSciences?


OverviewRevenueFinancialsChart

Greenwich LifeSciences Ownership Summary


Greenwich LifeSciences is owned by 4.76% institutional investors, 50.71% insiders, and 44.53% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 3.18% of GLSI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.57% of its assets in Greenwich LifeSciences shares.

GLSI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGreenwich LifeSciences4.76%50.71%44.53%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de433.86K3.18%$10.42M
Blackrock308.91K2.40%$5.33M
Vanguard group296.62K2.17%$6.23M
Geode capital management155.47K1.14%$3.74M
State street133.88K0.98%$3.22M
Nuveen88.72K0.65%$2.13M
Northern trust75.13K0.55%$1.80M
Bank of new york mellon46.52K0.34%$1.12M
Vanguard fiduciary trust44.91K0.33%$1.08M
Russell investments group39.70K0.29%$953.55K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Eam investors21.43K0.06%$514.75K
Ancora advisors37.50K0.02%$900.75K
Newbridge financial services group2.10K0.01%$50.44K
Strs ohio13.70K0.00%$329.07K
State of wisconsin investment board20.34K0.00%$488.54K
Russell investments group39.70K0.00%$953.55K
Tower research capital llc (trc)1.42K0.00%$34.11K
Marshall wace, llp25.66K0.00%$616.31K
Sei investments26.09K0.00%$626.63K
Nuveen88.72K0.00%$2.13M

Top Buyers

HolderShares% AssetsChange
Blackrock308.91K0.00%252.45K
Nuveen88.72K0.00%88.72K
Blackrock funding, inc. /de433.86K0.00%62.40K
Vanguard fiduciary trust44.91K0.00%44.91K
Russell investments group39.70K0.00%39.14K

Top Sellers

HolderShares% AssetsChange
Credit agricole s a---87.00K
Renaissance---38.40K
Susquehanna group, llp---35.87K
Virtu financial---28.80K
Man group---28.07K

New Positions

HolderShares% AssetsChangeValue
Nuveen88.72K0.00%88.72K$2.13M
Vanguard fiduciary trust44.91K0.00%44.91K$1.08M
Ancora advisors37.50K0.02%37.50K$900.75K
Sei investments26.09K0.00%26.09K$626.63K
Eam investors21.43K0.06%21.43K$514.75K

Sold Out

HolderChange
Capital performance advisors llp-1.00
True wealth design-2.00
Sbi securities-30.00
Global retirement partners-45.00
Hopwood financial services-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202629-40.82%649,428-51.06%45.03%16-30.43%7-56.25%
Dec 31, 202533-35.29%1,070,551-11.83%79.52%16-27.27%9-30.77%
Sep 30, 202538-19.15%1,062,357-10.67%79.75%14-46.15%8-20.00%
Jun 30, 20255113.33%1,231,6866.00%911.73%2993.33%10-23.08%
Mar 31, 20254410.00%1,143,322-1.62%811.24%15-28.57%13160.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv217.78K1.57%-
Vanguard US Total Market Shares ETF153.46K1.17%-
iShares Russell 2000 ETF153.19K1.11%1.27K
PV BUYBACK USA Classe B USD87.00K0.63%-
CREF Total Global Stock Account R380.59K0.58%-4.86K
Vanguard Institutional Extnd Mkt Idx Tr72.53K0.52%-
Fidelity Small Cap Index61.48K0.44%660.00
iShares Russell 2000 Growth ETF51.92K0.37%134.00
State St Russell Sm/Mid Cp® Indx SL Cl I43.01K0.31%-
Russell 2000 Equity Index Fund B38.10K0.28%-10.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 13, 2026Patel Snehal CEO and CFOBuy$53.69K
Jan 12, 2026Patel Snehal CEO and CFOBuy$79.87K
Dec 31, 2025Patel Snehal CEO and CFOBuy$91.85K
Dec 30, 2025Patel Snehal CEO and CFOBuy$63.02K
Dec 18, 2025Patel Snehal CEO and CFOBuy$51.74K

Insider Transactions Trends


DateBuySell
2026 Q12-
2025 Q46-
2025 Q24-
2025 Q15-
2024 Q43-

GLSI Ownership FAQ


Who Owns Greenwich LifeSciences?

Greenwich LifeSciences shareholders are primarily institutional investors at 4.76%, followed by 50.71% insiders and 44.53% retail investors. The average institutional ownership in Greenwich LifeSciences's industry, Biotech Stocks , is 35.75%, which Greenwich LifeSciences falls below.

Who owns the most shares of Greenwich LifeSciences?

Greenwich LifeSciences’s largest shareholders are Blackrock funding, inc. /de (433.86K shares, 3.18%), Blackrock (308.91K shares, 2.40%), and Vanguard group (296.62K shares, 2.17%). Together, they hold 7.76% of Greenwich LifeSciences’s total shares outstanding.

Does Blackrock own Greenwich LifeSciences?

Yes, BlackRock owns 2.40% of Greenwich LifeSciences, totaling 308.91K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.33M$. In the last quarter, BlackRock increased its holdings by 252.45K shares, a 447.14% change.

Who is Greenwich LifeSciences’s biggest shareholder by percentage of total assets invested?

Eam investors is Greenwich LifeSciences’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 21.43K Greenwich LifeSciences shares, valued at 514.75K$.

Who is the top mutual fund holder of Greenwich LifeSciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Greenwich LifeSciences shares, with 1.57% of its total shares outstanding invested in 217.78K Greenwich LifeSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools